MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant recipe aims to cut Graft-Versus-Host disease in blood cancer patients
Disease control Not yet recruitingThis early-phase study tests a new combination of chemotherapy drugs (thiotepa, busulfan, fludarabine) with a lower dose of post-transplant cyclophosphamide for stem cell transplants in people with certain blood cancers like leukemia and myelodysplastic syndrome. The goal is to s…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New drug combo aims to cut infections in blood cancer patients
Disease control Not yet recruitingThis study tests a new oral liquid drug, BLEX 404, combined with a standard chemotherapy (azacitidine) in adults with certain types of bone marrow cancers (MDS and CMML). The goal is to find a safe dose and see if it can reduce serious infections. About 52 people aged 20 and olde…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE2 • Sponsor: BioLite, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC